As everybody knows by now I called OTC trading

New Post Public Reply Private Reply Replies (3) Message Board

Jun 8, 2012 at 3:33 PM

As everybody knows by now I called OTC trading services(otcmarket.com-212-896-4420 or 1-800-547-8682 when the class was improperly imposed.
They told me the reason for the status change was a presumed newsletter PROMOTION(they assumed)but there was no promotion as noted by 1-30/31-11 CWRN PR etc.

I think promos are stupid and usually end up hurting co's but in the larger scheme of things -w all the fraud everywhere at every level running rampant in the market there is nothing illegal about a newsletter promo.

People who have been here for a while know this for this issue is often recycled.

That companies without current filings for which there is a promotion may receive the CE symbol-and for profit non regulatory otc is trying to force all co's to upgrade to current class so they slap ce without proof on hundreds of co's..

He said they look at a number of things-especially price changes and market activity.

This is what I suggested earlier.
Special interest groups complain because they are being killed by the price rise. OTC sees no current filings and sees the dramatic volatility,large volume and price rise of the stock.

The stock was not only gapping from day to day but intra-day-something I'd never seen before.
So they issue CE
He said they have no knowledge of any fraudulent activity and did not receive the status change because of any fraudulent activity.

One of the persons who first posted the suggestion of fraud-who has believed the same since 2006 and suggested that the pictures were fake,probably knows what I've just told you-because they are far more experienced at this game than I(I don't like games and won't play them and even my enemies recognize and are afraid of my integrity).

So ask yourself why they sounded the alarm under false pretense. Special interest groups have an agenda and it is always easier to take advantage of peoples fears to destroy than it is to build.
The false accusers know they win temporarily no matter what in this smear campaign scenario-the pink elephant syndrome.

the stock will recover because the fundamentals-actual production w multiple shiploads of stockpiled material-are there and the company has substantial revenues.

Most of you have traded many CE stocks up to at least $5/share because many of the companies promoted by stock newsletters had the CE status even BEFORE the promotion,for reasons other than a promotion. There are hundreds of such stocks.
There are over ten thousand stocks(a number which varies) in the grey market alone(otcmarkets.com)-a class below CWRN's recent no info status-no info itself is a misnomer -category where amount of info doesnt qualify for a higher category.

Cotton & Western Mining Inc. (CWRN) Stock Research Links

CWRN Board Company Profile Buy Rating Time & Sales News Filings Financials

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

NARUTO Card Game Set for June 2027 Global Launch

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Top 5 Most Recently Viewed Articles

IMCD Expands Reach in Latin America with Blumos Acquisition IMCD N.V. is making significant strides in the life science markets across Latin America through its recent acquisition of the Blumos Group. This move showcases IMCD's commitment to growing its footprint in the region, enhancing its distribution of specialty chemicals and ingredients. About Blumos Group Founded...

Insights on the Recent Decline of SolarEdge Technologies (SEDG)

Understanding the Decline of SolarEdge Technologies SolarEdge Technologies Inc (NASDAQ: SEDG) recently faced a notable decline in its stock price, falling by 5.47% to $17.96. This drop is part of a broader downward trend affecting clean energy stocks, triggered by concerns surrounding the pricing strategies and performance expectations of major players in the solar energy...

FCP Secures $16.7M for Multifamily Project in Lake Nona

FCP Closes $16.7 Million for Royal Palm at Nona Development FCP has announced a significant milestone by closing a $16.7 million preferred equity investment aimed at financing the Royal Palm at Nona project. This 320-unit, Class A multifamily development is set to rise in a rapidly growing submarket. The development is spearheaded by Royal Palm Companies, a reputable firm...

TeamLinkt Receives Growth Investment to Expand AI Sports Platform

TeamLinkt Gains Momentum with Strategic Investment TeamLinkt, a groundbreaking sports management platform, proudly announces a significant minority growth investment from Growth Street Partners. This investment marks an exciting chapter for TeamLinkt as it aims to enhance its technology and expand support services for sports leagues, clubs, and associations....

Glucose Health Validates Fiber's Importance for Public Well-Being

Glucose Health, Inc. Shines a Light on Dietary Fiber's Importance In an important recognition, the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Agriculture (USDA) have identified dietary fiber as a nutrient of public health concern. This announcement holds significant weight for Glucose Health, Inc. (OTC: GLUC), a leader in diabetic...